Mycosis fungoides echocardiography and ultrasound

Jump to: navigation, search

Mycosis fungoides Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides echocardiography and ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycosis fungoides echocardiography and ultrasound

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides echocardiography and ultrasound

CDC on Mycosis fungoides echocardiography and ultrasound

Mycosis fungoides echocardiography and ultrasound in the news

Blogs on Mycosis fungoides echocardiography and ultrasound

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

  • Echocardiography may be helpful in the diagnosis of mycosis fungoides.

Echocardiography/Ultrasound

Echocardiography may be helpful in the diagnosis of mycosis fungoides. Findings on an echocardiography suggestive mycosis fungoides include:[1]

  • ST/T wave and QT changes on EKG
  • Complete metabolic panel (CMP)
  • Romedepsis and vorinostat, histone deacetylase are also known to cause blood dyscrasias, ST/T wave and QT changes on EKG and GI side effects. In these patients, baseline EKG, complete metabolic panel (CMP) and complete blood count need to be obtained before infusion is initiated

References

  1. Duvic M, Vu J (December 2007). "Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat". Biologics. 1 (4): 377–92. PMC 2721288. PMID 19707308.

Linked-in.jpg